Hims & Hers Health: The GLP-1 Chaos Is Fading, The Thesis Is Still On Track [Seeking Alpha]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Seeking Alpha
HIMS's long-term platform thesis centers on becoming the go-to digital health platform, leveraging subscriber growth, data, and strategic partnerships for expansion. Despite near-term margin pressures and slower growth, HIMS trades at a compelling valuation with 2030 EV/EBITDA of 3.7 and significant upside if targets are met. I maintain a Buy rating, emphasizing HIMS's global expansion, resilient business model, and potential for further pharmaceutical partnerships. AlexSecret/iStock via Getty Images Introduction Hims & Hers Health, Inc. ( HIMS ) has been on a rollercoaster in the past months and weeks. It all started when their earnings continued showing a slowdown of their core business around October 2025. Peak-to-trough, the This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of HIMS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not r
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMSPR Newswire
- Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights [Yahoo! Finance]Yahoo! Finance
- UnitedHealth, Hims & Hers, Gambling.Com - Value Investing With Raul Shah [Seeking Alpha]Seeking Alpha
- Hims & Hers Health, Inc. Investigated by the Portnoy Law FirmGlobeNewswire
- Hims And Hers Health Pushes Into Complex Care And Global Growth [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 2/23/26 - Beat
HIMS
Sec Filings
- 3/18/26 - Form 4
- 3/18/26 - Form 4
- 3/18/26 - Form 4
- HIMS's page on the SEC website